Inhibition of androgen independent prostate cancer cells by small molecules

Natalya Narizhneva , Natalia Tararova , Vera Shakhova , Pavel Komarov
Cancer Research 68 1315 -1315

1
2008
Reversan, a novel inhibitor of MRP1, increases the therapeutic index of conventional chemotherapeutic agents

Katerina Gurova , Catherine Burkhart , Andrei Gudkov , Janice Smith
Cancer Research 68 3242 -3242

2008
Apoptosis mediated by extracellular matrix proteins and p53 prevents full in vitro transformation of human fibroblasts.

Aatur Singhi , Vadim Krivokrysenko , Katerina Gurova , George Stark
Cancer Research 67 3047 -3047

2007
Mycoplasma infection suppresses p53, activates NF-kappaB and cooperates with oncogenic Ras in rodent fibroblast transformation

Dmitry Scheblyakov , Lyudmila Burdelya , Katerina Gurova , Andrei Gudkov
Cancer Research 68

20
2008
Molecular targeted therapies and precision medicine for children with neuroblastoma and other refractory malignancies

Michelle Haber , Laura Gamble , Lin Xiao , Ruby Pandher
Cancer Research 80 ( 14)

2020
Dual targeting of the epigenome via FACT complex and histone deacetylase is a potent treatment strategy for DIPG.

Anahid Ehteda , Sandy Simon , Laura Franshaw , Federico M Giorgi
Cell Reports 35 ( 2) 108994 -108994

2021
AKT2 is frequently upregulated in HER-2/neu-positive breast cancers and may contribute to tumor aggressiveness by enhancing cell survival.

Sarah S Bacus , Deborah A Altomare , Ljuba Lyass , Dot Mon Chin
Oncogene 21 ( 22) 3532 -3540

129
2002
Structure and function of the histone chaperone FACT - Resolving FACTual issues.

Katerina Gurova , Han-Wen Chang , Maria E. Valieva , Poorva Sandlesh
Biochimica et Biophysica Acta 1861 ( 9) 892 -904

42
2018
Prognostic value of histone chaperone FACT subunits expression in breast cancer.

Kristopher Attwood , Daria Fleyshman , Laura Prendergast , Geraldine Paszkiewicz
Breast Cancer: Targets and Therapy 9 301 -311

14
2017
Functional Genomics and Computational Approaches Identify Novel Small Molecules Targeting Quiescent Leukemia Stem Cells

Costakis Frangou , Jason Den Haese , Jordan Warunek , Scott Portwood
Blood 126 ( 23) 1391 -1391

2015
Level of FACT defines the transcriptional landscape and aggressive phenotype of breast cancer cells.

Daria Fleyshman , Laura Prendergast , Alfiya Safina , Geraldine Paszkiewicz
Oncotarget 8 ( 13) 20525 -20542

24
2017
Histone chaperone FACT is essential to overcome replication stress in mammalian cells.

Laura Prendergast , Erin Hong , Alfiya Safina , Dante Poe
Oncogene 39 ( 28) 5124 -5137

3
2020
Quinacrine Overcomes Resistance to Erlotinib by Inhibiting FACT, NF-κB, and Cell-Cycle Progression in Non–Small Cell Lung Cancer

Josephine Kam Tai Dermawan , Katerina Gurova , John Pink , Afshin Dowlati
Molecular Cancer Therapeutics 13 ( 9) 2203 -2214

38
2014
ARTIK-52 induces replication-dependent DNA damage and p53 activation exclusively in cells of prostate and breast cancer origin.

Daria Fleyshman , Peter Cheney , Anda Ströse , Shaila Mudambi
Cell Cycle 15 ( 3) 455 -470

2
2016